GLINIL

Description

GLINIL Tablet is an oral antidiabetic medicine manufactured by Cipla Ltd, containing Glibenclamide (5mg) as its active ingredient. It belongs to the sulfonylurea class of medicines and is prescribed for the management of type 2 diabetes mellitus.

How it works:
Glibenclamide lowers blood glucose levels by stimulating the pancreas to release more insulin. The increased insulin secretion helps the body utilize glucose more effectively, thereby reducing high blood sugar.

Key Benefits:

• Effective in lowering blood sugar in type 2 diabetes.

• Helps reduce the risk of diabetes-related complications such as kidney damage, nerve problems, and vision impairment.

• Can be prescribed alone or in combination with other antidiabetic medicines.

Usage & Dosage:

• Taken orally, usually once or twice daily before meals.

• Dosage is individualized by the doctor based on the patient’s blood sugar levels and response.

• Regular use with proper diet and exercise ensures better diabetes control.

Safety Advice:

• Not suitable for type 1 diabetes or diabetic ketoacidosis.

• May cause hypoglycemia if meals are missed, after excessive exercise, or with alcohol consumption.

• Caution required in patients with kidney, liver, or heart conditions.

• Blood sugar levels should be monitored regularly during treatment.

Possible Side Effects:

• Low blood sugar (shakiness, sweating, hunger, palpitations)

• Headache, dizziness

• Nausea, stomach upset

• Weight gain in some patients

• Rarely, skin rash or allergic reaction